Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isovitexin is a naturally occurring flavone, specifically the apigenin 6-C-glucoside, found in various medicinal plants such as passion flower, Cannabis, oat, and açaí palm. It is structurally related to vitexin (apigenin 8-C-glucoside) but differs by the position of its glucose moiety[5][1]. Isovitexin exhibits a range of pharmacological activities including anti-inflammatory, antioxidant, anticancer (notably against colon cancer), neuroprotective, and analgesic effects[2][4][10]. Mechanistically, it has been shown to inhibit pro-inflammatory cytokine expression (e.g., TNF-alpha, IFN-gamma), induce apoptosis in activated T cells and tumor cells via caspase activation and PARP cleavage[7][10], and suppress PI3K/Akt/mTOR signaling pathways implicated in cancer cell survival[10]. Isovitexin is widely studied as an active component of traditional Chinese medicines for its potential therapeutic benefits across multiple disease models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isovitexin.